| Clinical data | |
|---|---|
| Other names | Tropine benzylate, BAT, TB, #9447, BETE, BTE, Glykin, Glypin |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.125.953 |
| Chemical and physical data | |
| Formula | C22H25NO3 |
| Molar mass | 351.446 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tropine benzilate also known asglipin is an ester formed betweentropine andbenzilic acid.[1] Like its structural relatives such as atropine and scopolamine, tropine benzilate is considered amuscarinic antagonist, meaning it binds to and blocksmuscarinic acetylcholine receptors in the nervous system and various tissues.
The substance was first described in 1936 and was shown to relaxsmooth muscle and block signals from thevagus nerve.[2] It was also later shown to block stomach acid secretion in dogs.[3]
It is a chemicaldeliriant similar to two related substances, namely3-quinuclidinyl benzilate andCS-27349.Atropine is also based on tropine alkaloid but differs in the structure in that it containstropic acid and notbenzilic acid for the aromatic portion of the ester moiety. Tropine benzilate is less commonly sold as a tertiary amine, but is usually encountered as the quaternary amineFlutropium bromide.
Tropine benzilate may be synthesized by reacting tropine with methyl benzilate in atransesterification reaction.[4]